We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Final Rule on Drug Company “Right to Try” Annual Reports
FDA Issues Final Rule on Drug Company “Right to Try” Annual Reports
After getting fewer than 50 comments on the proposed rule, the FDA has issued its final rule on the annual report pharmaceutical companies must submit on drugs they supplied under the Right to Try Act, a law that allows patients with life-threatening conditions access to certain unapproved investigational drugs and biological products.